Medicine:Microphthalmia–dermal aplasia–sclerocornea syndrome
From HandWiki
Microphthalmia–dermal aplasia–sclerocornea syndrome | |
---|---|
Other names | MIDAS syndrome[1] |
Microphthalmia–dermal aplasia–sclerocornea syndrome is a condition characterized by linear skin lesions.[1][2] MLS is a rare X-linked dominant male-lethal disease characterized by unilateral or bilateral microphthalmia and linear skin defects in affected females, and in utero lethality for affected males.[3] It can be associated with HCCS,[4] mutations in it cause microphthalmia with Linear Skin Defects Syndrome.[5]
See also
- List of cutaneous conditions
References
- ↑ 1.0 1.1 Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
- ↑ Happle, R.; Daniëls, O.; Koopman, R. J. J. (1993). "MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome". American Journal of Medical Genetics 47 (5): 710–3. doi:10.1002/ajmg.1320470525. PMID 8267001.
- ↑ Linear Skin Defects with Multiple Congenital Anomalies, http://www.omim.org/entry/309801
- ↑ "Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome". Am. J. Hum. Genet. 79 (5): 878–89. November 2006. doi:10.1086/508474. PMID 17033964.
- ↑ "Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome". Am. J. Hum. Genet. 79 (5): 878–89. 2006. doi:10.1086/508474. PMID 17033964.
External links
Classification | |
---|---|
External resources |
Original source: https://en.wikipedia.org/wiki/Microphthalmia–dermal aplasia–sclerocornea syndrome.
Read more |